(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1\\\',2\\\':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid1616342-45-0,Purity98%

Home>Supplier>NANJING ZENJI PHARMACEUTICAL CO.，LTD>(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1\\\',2\\\':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid

NANJING ZENJI PHARMACEUTICAL CO.，LTD

: Certified Store

: Production/Manufacturing

: China Jiangsu Nanjing

: anna@zenjipharma.com

: 13770710485

Hot Search

Ethyl (3,5,6)-6-ethyl-3-hydroxy-7-oxo-cholan-24-oate

CAS NO.: 459789-97-0

Purity :98%

4-Aminomethyltetrahydropyran

CAS NO.: 130290-79-8

Purity :98%

N-(tert-butyl)-1H-indazole-7-carboxamide

CAS NO.: 1476776-76-7

Purity :98%

6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylic acid

CAS NO.: 1256584-78-7

Purity :98%

Ribociclib

CAS NO.: 1374639-75-4

Purity :98%

Catalog No. : B002

(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1\\\',2\\\':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid

CAS No : 1616342-45-0
Packing : 1kg
Brand :
Purity : 98%
Loading Port :
Lead Time : 7Day (s)

Packing :

1kg

Request For Quotation

Product Details & Description

Product Info

Compound
CAS No.	1616342-45-0	Catalog No.	B002	Brand
Purity	98%	Packing	1kg	Grade
Lead Time	7Day (s)	Origin		Loading Port

Request For Quotation

Product: (2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1\\\',2\\\':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid

Cas No: 1616342-45-0

*Purity

*Quantity

*Valid for

*Shipping To

Contact Person

*Email

*Company/Institute

Notes

I would like to have suppliers recommended by MOLBASE.

I agree to share my contact information to the supplier(s).

Other Supplier Reference

Product Name	Purity	Packing	Lead Time	Country	Store Name	Details
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid	98%	1kg,100kg 3 spec	IN STOCK	China,Zhejiang	Hangzhou J&H Chemical Co., Ltd.	Request For Quotation
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid	98%	10kg	3Day (s)	China,Henan	Henan Coreychem Co.,Ltd	Request For Quotation
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid		10kg,50kg	IN STOCK	China,Beijing	BIONNA	Request For Quotation
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1\',2\':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid	98%	1kg	7Day (s)	China,Zhejiang	Hangzhou Shangjie Chemical Co., Ltd.	Request For Quotation
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1\',2\':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid	98%	1kg	7Day (s)	China,Shanghai	Shanghai Tongchang Biomedical Technology Co., Ltd.	Request For Quotation

View All Suppliers

Related Products

Narciclasine

CAS No : 29477-83-6
[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfamate

CAS No : 148672-09-7
(1R,2S,3S,4S,4aR,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one

CAS No : 96203-70-2
4,7-Methanoisobenzofuran-5,6-imine-1,3-dione, hexahydro-9-(phenylsulfonyl)-

CAS No : 6410-70-4
Hiprex

CAS No : 5714-73-8
[(4aS,5R,5aS,6aR,6bS)-3-(Hydroxymethyl)-6b-methyl-2-oxo-2,4,4a,5, 5a,6,6a,6b-octahydrocyclopropa[2,3]indeno[5,6-b]furan-5-yl]methyl acetate

CAS No : 1136932-34-7
(6-Methoxy-1,5-dimethyl-4,7-dioxo-1,1a,2,4,7,8b-hexahydroazireno[ 2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate

CAS No : 15973-07-6
Paeoniflorigenone

CAS No : 80454-42-8

Chemical Product Chemical Encyclopedia Structure CAS Number Search

Compound Synonyms: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9

Home Partners Business Cooperation Suppliers About Us Contact Us Privacy Policy Terms & Conditions Disclaimer